Senores Pharmaceuticals Results Earnings Call for Q1FY27

Senores Pharmaceuticals Ltd.

NSE: SENORES | BSE: 544319 | ISIN: INE0RB801010 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1506.9000 9.40 (0.63%)

NSE Sep 08, 2026 14:36 PM

127.47% Gain from 52W Low

Volume: 332.3K

Conference/Earnings Calls Alerts

Senores Pharmaceuticals Ltd.

27 Jul 2026

1506.90

0.63%

Senores Pharmaceuticals Results Earnings Call for Q1FY27

Conference Call with Senores Pharmaceuticals Management and Analysts on Q1FY27 Performance and Outlook. Listen to the full earnings transcript.

More from Senores Pharmaceuticals Ltd.

Recommended

Market trades lower, Suzlon Energy wins a 200 MW wind energy order

Trendlyne Marketwatch | 08 Sep 2026, 02:15PM

IPO market gains momentum as Rentomojo leads a crowded pipeline

| 07 Sep 2026, 06:13PM

Pre Monday: Good market signals for the coming week, except for one party spoiler

The Baseline | 05 Sep 2026